<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="26817">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT02006615</url>
  </required_header>
  <id_info>
    <org_study_id>2013-07-011A</org_study_id>
    <nct_id>NCT02006615</nct_id>
  </id_info>
  <brief_title>The Role of Primary Motor Cortex and Prefrontal Cortex for Facilitation of Motor System and Working Memory</brief_title>
  <official_title>The Role of Primary Motor Cortex and Prefrontal Cortex for Facilitation of Motor System and Working Memory in Stroke, Parkinson, and Elderly Patients</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Taipei Veterans General Hospital, Taiwan</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Taipei Veterans General Hospital, Taiwan</source>
  <oversight_info>
    <authority>Taiwan : Food and Drug Administration</authority>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      We hypothesize that ten sessions of repetitive transcranial magnetic stimulation yield
      ability to upregulate the function of primary motor cortex and prefrontal cortex that play
      key roles in motor and frontal memory processing.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Excitatory (&gt;3Hz) rTMS could facilitate the brain cortex and neuroplasticity that benefits
      motor control and working memory when the coil is applied over primary motor cortex or
      dorsolateral prefrontal gyrus.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>July 2013</start_date>
  <completion_date type="Anticipated">July 2015</completion_date>
  <primary_completion_date type="Anticipated">July 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Outcomes Assessor), Primary Purpose: Treatment</study_design>
  <primary_outcome>
    <measure>Repeatable Battery for the Assessment of Neuropsychological Status</measure>
    <time_frame>up to 3 months</time_frame>
    <safety_issue>No</safety_issue>
  </primary_outcome>
  <secondary_outcome>
    <measure>Reaction time</measure>
    <time_frame>up to 3 months</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">150</enrollment>
  <condition>Central Nervous System Diseases</condition>
  <arm_group>
    <arm_group_label>5Hz rTMS</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>rTMS group</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Sham rTMS</arm_group_label>
    <arm_group_type>Sham Comparator</arm_group_type>
    <description>Sham stimulation</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>rTMS</intervention_name>
    <description>5Hz rTMS over M1 and inferior frontal lobe</description>
    <arm_group_label>5Hz rTMS</arm_group_label>
    <arm_group_label>Sham rTMS</arm_group_label>
    <other_name>Magstim rapid2</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Ischemic or hemorrhagic cerebrovascular lesion, Parkinsonism disease, elderly people

        Exclusion Criteria:

          -  Seizure, metalic implantation, other contra-indications for TMS; Dementia or severe
             cognitive impairment
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>30 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Po-Yi Tsai, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Taipei Veterans General Hospital, Taiwan</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Po-Yi Tsai, MD</last_name>
    <phone>886-228757293</phone>
    <email>vivitsai0518@gmail.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Chih-Jou Lai, MD</last_name>
    <phone>886-228757361</phone>
    <email>milly1204@gmail.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Taipei Veterans General Hospital</name>
      <address>
        <city>Taipei</city>
        <zip>11217</zip>
        <country>Taiwan</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Po-Yi Tsai, MD</last_name>
      <phone>886-228757293</phone>
      <email>vivitsai0518@gmail.com</email>
    </contact>
  </location>
  <location_countries>
    <country>Taiwan</country>
  </location_countries>
  <link>
    <url>http://www.ncbi.nlm.nih.gov/pubmed/23194830</url>
  </link>
  <link>
    <url>http://www.ncbi.nlm.nih.gov/pubmed/21980359</url>
  </link>
  <link>
    <url>http://www.ncbi.nlm.nih.gov/pubmed/19309294</url>
  </link>
  <verification_date>December 2013</verification_date>
  <lastchanged_date>December 5, 2013</lastchanged_date>
  <firstreceived_date>December 5, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Taipei Veterans General Hospital, Taiwan</investigator_affiliation>
    <investigator_full_name>vghtpe user</investigator_full_name>
    <investigator_title>MD</investigator_title>
  </responsible_party>
  <is_fda_regulated>Yes</is_fda_regulated>
  <is_section_801>Yes</is_section_801>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Central Nervous System Diseases</mesh_term>
    <mesh_term>Nervous System Diseases</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
